TABLE 2.
n (%) | |
Type of DR-TB | |
Correct | 46 (94) |
Incorrect | 1 (2) |
Missing | 2 (4) |
Confirmation of TB diagnosis | |
Correct | 38 (78) |
Incorrect | 9 (18) |
Confirmed, indicated as not confirmed* | 8 |
Not confirmed, indicated as confirmed | 1 |
Missing | 2 (4) |
Disease spectrum | |
PTB (n = 34) | |
Correct | 27 (79) |
Incorrect | 4 (12) |
Missing | 3 (9) |
EPTB (n = 6) | |
Correct | 5 (83) |
Incorrect | 0 |
Missing | 1 (17) |
Both PTB and EPTB (n = 9) | |
Indicated as PTB† | 5 (56) |
Indicated as extra-pulmonary TB | 3 (33) |
Missing | 1 (11) |
Total correct | 37 (76) |
Started on treatment (n = 49) | |
Yes | 41 (84) |
Missing | 8 (16) |
Current treatment start date | |
Within 1 week | 29 (59) |
Within 1 month | 6 (12) |
>1 month | 6 (12) |
Missing (same as missing started on treatment) | 8 (16) |
Current treatment | |
Correct | 28 (57) |
Some second-line drugs missing | 12 (24) |
All missing | 9 (18) |
HIV status | |
Positive (n =10) | |
Correct and all indicated as starting ART | 10 (100) |
Negative (n = 35) | |
Correct | 27 (77) |
Incorrect (indicated ‘positive’ or ‘unknown’) | 2 (6) |
Missing | 6 (17) |
Missing in clinical data set (n = 4) | |
Indicated as HIV-negative in EDR.web | 4 (100) |
6 of those indicated as not confirmed had culture/LPA results entered indicating confirmation of drug resistance.
WHO recommendation to report as PTB if both PTB and EPTB. Not possible to enter as both in EDR.web.
DR-TB = drug-resistant tuberculosis; PTB = pulmonary TB; EPTB = extra-pulmonary TB; HIV = human immunodeficiency virus; ART = antiretroviral treatment; LPA = line probe assay; WHO = World Health Organization.